A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World Setting

Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis

NCT05572567 ·Status: COMPLETED

Predictors of Response to Tofacitinib Treatment in Rheumatoid Arthritis Patients

NCT04079920 ·Status: COMPLETED

Patients With Rheumatoid Arthritis (RA) Treated With Rituximab in Kuopio University Hospital

NCT00854321 ·Status: COMPLETED

Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR)

NCT04018001 ·Status: COMPLETED

Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)

NCT02097524 ·Status: COMPLETED ·Phase: PHASE1

A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid Arthritis

NCT04721808 ·Status: COMPLETED

A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid Arthritis

NCT02281552 ·Status: COMPLETED ·Phase: PHASE3

Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis

NCT01765374 ·Status: COMPLETED ·Phase: PHASE4

The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis

NCT05133297 ·Status: COMPLETED ·Phase: PHASE2

Prospective Validation of a Pharmacological Biomarker for Low-Dose Rituximab in Rheumatoid Arthritis

NCT06933134 ·Status: RECRUITING

Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis

NCT01500551 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE

NCT04413617 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis

NCT00299130 ·Status: COMPLETED ·Phase: PHASE3

A Study on Rheumatoid Arthritis Patients Treated With Rituximab

NCT02622503 ·Status: COMPLETED

An Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local Environment

NCT01254331 ·Status: COMPLETED ·Phase: PHASE3

Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis

NCT00963703 ·Status: COMPLETED ·Phase: NA

Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis

NCT01976364 ·Status: COMPLETED ·Phase: PHASE3

An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Adults With Rheumatoid Arthritis

NCT02049138 ·Status: COMPLETED ·Phase: PHASE2

An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate

NCT02187055 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients

NCT01559103 ·Status: TERMINATED ·Phase: PHASE1

Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis

NCT04871919 ·Status: ACTIVE_NOT_RECRUITING

Real-life Experience of Tofacitinib in Patients With Treatment-Resistant Rheumatoid Arthritis

NCT04674085 ·Status: COMPLETED

Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis

NCT00413699 ·Status: COMPLETED ·Phase: PHASE3

A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A Day

NCT04267380 ·Status: COMPLETED

Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis

NCT02831855 ·Status: COMPLETED ·Phase: PHASE4